This is the first approval for company's transdermal product in the US, it added.
The product will be manufactured at Zydus Technologies Ltd located at SEZ in Ahmedabad, Zydus Cadila said.
Also Read: Zydus Cadila gets USFDA nod to Doxazosin for treating BP, enlarged prostate issues
The tablets will be manufactured at the group's formulations manufacturing facility at SEZ in Ahmedabad, Zydus Cadila said.
Rosuvastatin works by reducing the amount of cholesterol made by the liver. It is used along with a proper diet to help lower 'bad' cholesterol and raise 'good' cholesterol in the blood, it added.
The group now has 252 approvals and has so far filed over 350 abbreviated new drug applications (ANDAs) since the commencement of the filing process, Zydus Cadila said.
Also Read: Zydus receives USFDA nod for Phytonadione, Colchicine tablets
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd